Gene · 951
Papers1,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma. | Elife | 2026 | 42474002 | PubTator, text mining | PubMed |
| Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin's lymphoma. | J Immunother Cancer | 2026 | 42413982 | PubTator, text mining | PubMed |
| Radiometabolic Therapy in Lymphoma: From Radioimmunotherapy to Emerging Theranostic and Combination Strategies. | Cancers (Basel) | 2026 | 42352493 | PubTator, text mining | PubMed |
| Progressive suppression of regulated cell death defines terminal macrophage states in liver cirrhosis. | Ann Med | 2026 | 42345211 | PubTator, text mining | PubMed |
| The search for safe and effective CAR-T targets in AML. | Blood Cancer J | 2026 | 42321183 | PubTator, text mining | PubMed |
| C1q-targeting bispecific antibodies bypass Fc to trigger complement activation and receptor clustering agonism. | Mol Immunol | 2026 | 42285030 | PubTator, text mining | PubMed |
| A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies. | J Hematol Oncol | 2026 | 42216090 | PubTator, text mining | PubMed |
| Bispecific CD37-Siglec6 CAR‑T cells exhibit enhanced anti‑leukemic activity and reduced exhaustion in acute myeloid leukemia xenograft models. | J Transl Med | 2026 | 42035126 | PubTator, text mining | PubMed |
| Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS. | Cell Rep Med | 2026 | 42013843 | PubTator, text mining | PubMed |
| Comparative proteomics reveals protein signatures shared between and unique to bona fide plant EVs and other plant-derived vesicles. | Plant Physiol | 2026 | 41914509 | PubTator, text mining | PubMed |
| Targeting sialic acid metabolism: a therapeutic strategy against gastric cancer driven by WZ35. | Cell Oncol (Dordr) | 2026 | 41870836 | PubTator, text mining | PubMed |
| Single-cell analysis of a salmonid immune system (river brown trout Salmo trutta fario) reveals evolutionary divergence and hatchery-induced transcriptional reprogramming. | BMC Biol | 2026 | 41845393 | PubTator, text mining | PubMed |
| Integrating computational engines to identify TSPAN6 as a migrasome-associated target for immunotherapy sensitization. | Front Immunol | 2026 | 41782878 | PubTator, text mining | PubMed |
| Integrated single cell multiomic profiling and functional validation reveal distinct cellular routes to human plasma cell differentiation. | bioRxiv | 2026 | 41756891 | PubTator, text mining | PubMed |
| Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy. | Pharmaceuticals (Basel) | 2026 | 41754865 | PubTator, text mining | PubMed |
| A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients. | Pharmaceuticals (Basel) | 2026 | 41754790 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Biomarkers and Non-Surgical Therapeutics in Cardiovascular Diseases. | J Clin Med | 2026 | 41753224 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Targeted Treatment of Richter Transformation. | Biomedicines | 2026 | 41751246 | PubTator, text mining | PubMed |
| Controlling Biogenesis and Engineering of Exosomes to Inhibit Growth and Promote Death in Glioblastoma Multiforme. | Brain Sci | 2026 | 41750131 | PubTator, text mining | PubMed |
| ScRNA-seq Identifies High CXCL8 Linked to Liver Fibrosis in HBeAg-negative Chronic Hepatitis B Patients With Low HBsAg. | Gastro Hep Adv | 2026 | 41716597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/951/papers